-
Coronary Angiography after Cardiac Arrest — The Right Timing or the Right Patients?BS Abella, DF Gaieski. -
Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events in the ODYSSEY OUTCOMES TrialM Szarek, HD White, PH Steg, ODYSSEY OUTCOMES Committees and Investigators.
-
Healthy Behavior, Risk Factor Control, and Survival in the COURAGE TrialDJ Maron, GBJ Mancini, COURAGE Trial Group et al.
-
Potential protective mechanisms of green tea polyphenol EGCG against COVID-19Y Zhang, B Wernly, ZCh Zhou et al.
-
Qualitative and Mixed Methods Provide Unique Contributions to Outcomes ResearchCurry LA, Nembhard IM, Bradley EH.
-
Limitations of Repeat Revascularization as an Outcome MeasureP Lamelas, J Belardi, R Whitlock et al.
-
Prognostic implication of lipidomics in patients with coronary total occlusion undergoing PCIY Zhou, XD Wang, JY Qian et al.
-
Significantly less inappropriate shocks in ischemic patients compared to non-ischemic patients: The S-ICD experience of a high volume single-centerE Oosterwerff, A Adiyaman, A Elvan et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
